Aramark·4

Feb 4, 4:33 PM ET

SADOVE STEPHEN I 4

4 · Aramark · Filed Feb 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Aramark (ARMK) Director Stephen I. Sadove Receives Award

What Happened
Stephen I. Sadove, a director of Aramark (ARMK), received a grant of 7,751 deferred stock units on February 3, 2026. The filing lists a per-unit value of $38.06, for a total grant value of $295,003. This was an award (code A), not a purchase or sale — a form of director compensation rather than an open-market transaction.

Key Details

  • Transaction type: Award of deferred stock units (Form 4 code A).
  • Date and price: 2026-02-03 at $38.06 per unit.
  • Quantity and value: 7,751 units; aggregate value $295,003 (based on reported per-unit value).
  • Shares owned after transaction: Not disclosed in this Form 4.
  • Footnote: Grant is of deferred stock units that vest the day before the first annual shareholders’ meeting after the grant date (subject to continued service); if vested, units will be settled in shares on the first day of the seventh month after the director’s departure. (See F1.)
  • Filing timeliness: Reported on 2026-02-04 for a 2026-02-03 grant — appears timely.

Context
Deferred stock units are a common form of non‑cash director compensation. They do not represent immediately issued common shares and only convert to stock if vesting conditions are met; settlement is delayed per the footnote. Such awards are routine and reflect compensation practices rather than an insider buying or selling shares on the market.

Insider Transaction Report

Form 4
Period: 2026-02-03
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-03$38.06/sh+7,751$295,003102,049.114 total
Holdings
  • Common Stock

    (indirect: By Trust)
    15,000
Footnotes (1)
  • [F1]Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.
Signature
/s/ Ryan S. Spengler, as Attorney-in-fact|2026-02-04

Documents

1 file
  • 4
    wk-form4_1770240819.xmlPrimary

    FORM 4